| 000 | 01673 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518073352.0 | ||
| 264 | 0 | _c20210621 | |
| 008 | 202106s 0 0 eng d | ||
| 022 | _a2164-554X | ||
| 024 | 7 |
_a10.1080/21645515.2019.1697595 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOjeda, Joyce | |
| 245 | 0 | 0 |
_aImmunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. _h[electronic resource] |
| 260 |
_bHuman vaccines & immunotherapeutics _c06 2020 |
||
| 300 |
_a1380-1384 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAntibodies, Viral |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHemagglutination Inhibition Tests |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunogenicity, Vaccine |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfluenza B virus |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
| 650 | 0 | 4 |
_aVaccines, Inactivated _xadverse effects |
| 700 | 1 | _aArredondo, José Luis | |
| 700 | 1 | _aSalcedo, Perla | |
| 700 | 1 | _aParedes-Paredes, Mercedes | |
| 700 | 1 | _aDupuy, Martin | |
| 700 | 1 | _aPetit, Celine | |
| 700 | 1 | _aChabanon, Anne Laure | |
| 700 | 1 | _aRivas, Enrique | |
| 700 | 1 | _aGurunathan, Sanjay | |
| 700 | 1 | _aDe Bruijn, Iris | |
| 700 | 1 | _aPepin, Stephanie | |
| 773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 16 _gno. 6 _gp. 1380-1384 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21645515.2019.1697595 _zAvailable from publisher's website |
| 999 |
_c30394402 _d30394402 |
||